I think that international collaboration on therapeutics for pathogens and toxins continues to be very important to the development of the science.
I would say that, obviously, in hindsight, given the activities of these scientists and evidence of those activities, which emerged much later in that timeline, we would obviously look at decisions that were taken around their work sooner.
However, the work of collaboration on Ebola continued to be an international priority. Indeed, many countries—Canada, the United States and China included—were active in western Africa, responding on the ground to the Ebola outbreak. It was in that vein that the collaboration was approved and the work authorized.